Push Admin

NKTI suspends dispensing of COVID-19 drugs due to low supply

Article (news)

ABS-CBN News

<div class="embed-wrap"><figure data-feedback="fb:likes,fb:comments"><img alt="A health worker tends to a coronavirus disease (COVID-19) patient supported by a mechanical ventilator and undergoing dialysis at the COVID-19 emergency room of the government hospital National Kidney and Transplant Institute on April 26, 2021 in Quezon City, which has declared overcapacity following a surge of COVID-19 infections in Metro Manila. Eloisa Lopez, Reuters" src="https://sa.kapamilya.com/absnews/abscbnnews/media/2021/news/09/01/20210426-covid-hospital-nkti-rtr-4.jpg"/><figcaption>A health worker tends to a coronavirus disease (COVID-19) patient supported by a mechanical ventilator and undergoing dialysis at the COVID-19 emergency room of the government hospital National Kidney and Transplant Institute on April 26, 2021 in Quezon City, which has declared overcapacity following a surge of COVID-19 infections in Metro Manila.<em> Eloisa Lopez, Reuters</em></figcaption></figure></div><p>MANILA - The National Kidney and Transplant Institute (NKTI) will temporarily suspend the dispensing of drugs used to combat COVID-19 due to low supply, its chief said Wednesday.</p><p>The hospital has procured remdesivir and tocilizumab but is unsure when the supply will arrive, said Dr. Rose Marie Rosete-Liquete.</p><p>The hospital has 100 COVID-19 patients admitted, she added.</p><p>&quot;Kaya nagsabi kami na kukulangin tayo lalo sa tocilizumab dahil di pa dumadating ang aming procurement because wala nang supply sa supplier itself,&quot; she told ABS-CBN&#x27;s Teleradyo.</p><p>(That&#x27;s why we said we will lack tocilizumab because our procurement don&#x27;t arrive because the supplier itself has no supply.)</p><p>&quot;Wala pang kasiguruhan kung kailan darating.&quot;</p><p>(We&#x27;re not sure when it will arrive.)</p><p>The specialty hospital&#x27;s supply of hemoperfusion cartridges is also &quot;critical,&quot; Liquete said.</p><p>&quot;Meron pa pero critical na rin kasi almost more than 50 percent ng patients namin ay naghemoperfusion o dialysis din,&quot; she said.</p><p>(We still have some but the supply is critical because almost more than 50 percent of our patients undergo hemoperfusion or dialysis.)</p><p>The NKTI, meantime, cannot add more virus beds as it does not have enough manpower. Around 70 NKTI frontliners have resigned in the past month.</p><p>&quot;Kung may nagaaply man, may umaalis. Kailangan pa rin natin ng augmentation,&quot; she said.</p><p>(If there are people who apply, there are those who quit. We still need augmentation.)</p><figure class="op-interactive"><iframe allow="autoplay; fullscreen" frameBorder="0" height="100%" id="ivsplayer01" scrolling="no" src="https://player.ivideosmart.com/ivsplayer/v4/dist/html/iframe-src.html?iframeid=ivsplayer01&amp;key=e8c22c015ca9eafa76f1e3edfa03c603&amp;spid=3001339&amp;vid=1761705" width="100%"></iframe></figure><div class="iwantbar">Watch more in <a href="//www.iwantv.com.ph/">iWantv</a> or <a href="//tfc.tv/">TFC.tv</a></div>

The National Kidney and Transplant Institute (NKTI) will temporarily suspend the dispensing of drugs used to combat COVID-19 due to low supply, its chief said Wednesday.